Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹3,114 Cr
down ₹64.2 Cr vs Nov 2025
- Stocks held
- 31
- up 2 vs Nov 2025
- Top 10 weight
- 64.0%
- of the portfolio in its ten largest
- Cash & debt
- 1.0%
- cash, money market and debt
- Moves this month
- 2 in · 0 out
- added to 3, trimmed 22
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In December 2025 it disclosed 31 stocks worth ₹3,114 Cr, down ₹64.2 Cr from Nov 2025. Its largest positions were Cipla Limited (8.7%), Sun Pharmaceutical Industries Limited (8.5%), IPCA Laboratories Limited (7.7%); the ten largest together made up 64.0% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 64.1% of its equity. Cash and debt stood at 1.0%. Compared with Nov 2025 the fund entered 2 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
89%
Top-10 weight is higher than 89% of peers
Breadth
16%
Holds more stocks than 16% of peers
Cash
13%
Holds more cash than 13% of peers
Holdings in December 2025
Download CSVEvery line the fund disclosed, with the change against Nov 2025. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 8.69%
- Δ weight
- up 0.06 pts
- Value
- ₹271 Cr
- Δ value
- down ₹3.6 Cr
- Status
- Trimmed
- Weight
- 8.48%
- Δ weight
- down 0.37 pts
- Value
- ₹264 Cr
- Δ value
- down ₹17.2 Cr
- Status
- Trimmed
- Weight
- 7.73%
- Δ weight
- down 0.03 pts
- Value
- ₹241 Cr
- Δ value
- down ₹5.8 Cr
- Status
- Trimmed
- Weight
- 6.78%
- Δ weight
- down 0.11 pts
- Value
- ₹211 Cr
- Δ value
- down ₹7.9 Cr
- Status
- Trimmed
- Weight
- 6.52%
- Δ weight
- up 0.31 pts
- Value
- ₹203 Cr
- Δ value
- up ₹5.6 Cr
- Status
- Added
- Weight
- 6.07%
- Δ weight
- up 0.14 pts
- Value
- ₹189 Cr
- Δ value
- up ₹56 L
- Status
- Held
- Weight
- 5.23%
- Δ weight
- up 0.24 pts
- Value
- ₹163 Cr
- Δ value
- up ₹4.3 Cr
- Status
- Added
- Weight
- 5.09%
- Δ weight
- down 0.01 pts
- Value
- ₹159 Cr
- Δ value
- down ₹3.5 Cr
- Status
- Trimmed
- Weight
- 5.04%
- Δ weight
- down 0.23 pts
- Value
- ₹157 Cr
- Δ value
- down ₹10.6 Cr
- Status
- Trimmed
- Weight
- 4.40%
- Δ weight
- down 0.09 pts
- Value
- ₹137 Cr
- Δ value
- down ₹5.7 Cr
- Status
- Trimmed
- Weight
- 3.88%
- Δ weight
- down 0.20 pts
- Value
- ₹121 Cr
- Δ value
- down ₹8.7 Cr
- Status
- Trimmed
- Weight
- 3.21%
- Δ weight
- up 0.07 pts
- Value
- ₹100 Cr
- Δ value
- up ₹25 L
- Status
- Held
- Weight
- 3.19%
- Δ weight
- up 0.25 pts
- Value
- ₹99.3 Cr
- Δ value
- up ₹5.9 Cr
- Status
- Added
- Weight
- 3.07%
- Δ weight
- up 0.04 pts
- Value
- ₹95.6 Cr
- Δ value
- down ₹70 L
- Status
- Trimmed
- Weight
- 3.05%
- Δ weight
- down 0.07 pts
- Value
- ₹95 Cr
- Δ value
- down ₹4.1 Cr
- Status
- Trimmed
- Weight
- 2.92%
- Δ weight
- up 0.05 pts
- Value
- ₹90.8 Cr
- Δ value
- down ₹31 L
- Status
- Held
- Weight
- 2.44%
- Δ weight
- down 0.17 pts
- Value
- ₹75.9 Cr
- Δ value
- down ₹7 Cr
- Status
- Trimmed
- Weight
- 2.12%
- Δ weight
- down 0.07 pts
- Value
- ₹65.9 Cr
- Δ value
- down ₹3.5 Cr
- Status
- Trimmed
- Weight
- 1.70%
- Δ weight
- down 0.03 pts
- Value
- ₹53 Cr
- Δ value
- down ₹1.9 Cr
- Status
- Trimmed
- Weight
- 1.52%
- Δ weight
- up 0.02 pts
- Value
- ₹47.4 Cr
- Δ value
- down ₹20 L
- Status
- Held
- Weight
- 1.21%
- Δ weight
- down 0.04 pts
- Value
- ₹37.6 Cr
- Δ value
- down ₹2.2 Cr
- Status
- Trimmed
- Weight
- 1.14%
- Δ weight
- down <0.01 pts
- Value
- ₹35.6 Cr
- Δ value
- down ₹84 L
- Status
- Trimmed
- Weight
- 1.13%
- Δ weight
- down 0.01 pts
- Value
- ₹35.1 Cr
- Δ value
- down ₹1.1 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 1.02%
- Δ weight
- down 1.11 pts
- Value
- ₹31.9 Cr
- Δ value
- down ₹36 Cr
- Status
- Trimmed
- Weight
- 0.96%
- Δ weight
- up 0.96 pts
- Value
- ₹29.8 Cr
- Δ value
- up ₹29.8 Cr
- Status
- New
- Global X Funds - Global X Genomics & Biotechnology ETFFund units
- Weight
- 0.80%
- Δ weight
- up <0.01 pts
- Value
- ₹25 Cr
- Δ value
- down ₹38 L
- Status
- Trimmed
- Weight
- 0.66%
- Δ weight
- down 0.01 pts
- Value
- ₹20.6 Cr
- Δ value
- down ₹67 L
- Status
- Trimmed
- Weight
- 0.52%
- Δ weight
- up 0.52 pts
- Value
- ₹16.2 Cr
- Δ value
- up ₹16.2 Cr
- Status
- New
- Weight
- 0.50%
- Δ weight
- up 0.01 pts
- Value
- ₹15.5 Cr
- Δ value
- down ₹3 L
- Status
- Held
- Weight
- 0.42%
- Δ weight
- down 0.02 pts
- Value
- ₹13.1 Cr
- Δ value
- down ₹82 L
- Status
- Trimmed
- Weight
- 0.25%
- Δ weight
- up <0.01 pts
- Value
- ₹7.6 Cr
- Δ value
- down ₹13 L
- Status
- Trimmed
- Weight
- 0.22%
- Δ weight
- down 0.06 pts
- Value
- ₹6.7 Cr
- Δ value
- down ₹1.9 Cr
- Status
- Trimmed
- Weight
- 0.06%
- Δ weight
- down 0.06 pts
- Value
- ₹1.9 Cr
- Δ value
- down ₹2 Cr
- Status
- Trimmed
What changed, Nov 2025 to Dec 2025
New New positions (2)
- Nephrocare Health Services Ltd1.0% · ₹29.8 Cr
- Corona Remedies Limited0.5% · ₹16.2 Cr
Exited Exited (0)
None.
Added Biggest additions
- Vijaya Diagnostic Centre Limitedup ₹5.9 Cr (+0.25% pts)
- Laurus Labs Limitedup ₹5.6 Cr (+0.31% pts)
- Sai Life Sciences Limitedup ₹4.3 Cr (+0.24% pts)
Trimmed Biggest reductions
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Nov 2025, the weight rose most in Healthcare Services (+0.9 pts), and fell most in Pharmaceuticals & Biotechnology (−0.4 pts) and Pharmaceuticals (−0.3 pts).
- Healthcare Services17.8% → 18.7%+0.9 pts
- Pharmaceuticals & Biotechnology64.5% → 64.1%−0.4 pts
- Pharmaceuticals5.2% → 4.9%−0.3 pts
- Healthcare Equipment & Supplies10.5% → 10.3%−0.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Dec 2022 | Dec 2024 | Jun 2025 | Sep 2025 | Nov 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 63.9% | 66.4% | 67.0% | 67.7% | 64.5% | 64.1% |
| Healthcare Services | 18.9% | 17.3% | 16.7% | 17.2% | 17.8% | 18.7% |
| Healthcare Equipment & Supplies | 7.1% | 8.5% | 7.8% | 7.4% | 10.5% | 10.3% |
| Pharmaceuticals | 6.4% | 5.9% | 6.3% | 5.7% | 5.2% | 4.9% |
| Insurance | 2.6% | 1.3% | 1.6% | 1.5% | 1.5% | 1.5% |
| Retailing | 1.0% | 0.5% | 0.6% | 0.5% | 0.5% | 0.5% |
Allocation in Dec 2025change vs Nov 2025
- Pharmaceuticals & Biotechnology (15)64.1%▼ 0.4 pts
- Healthcare Services (8)18.7%▲ 0.9 pts
- Healthcare Equipment & Supplies (3)10.3%▼ 0.2 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Dec 2025
1.0%
▼ 1.1 pts vs Nov 2025
- Cash alone
- 1.0%
- cash and net receivables
- A year earlier
- 2.5%
- Dec 2024 · now ▼ 1.5 pts
- Last 12 months
- 0.1% – 2.2%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.